Albert Galera

Albert Galera

Auto-generated profile, based on publicly available information

Albert Galera

Medical Faculty, University of Basel, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2026 in BMC Cancer
Verified
Journal Article
Open access
PDF file
AGAlbert Galera
Albert Galera
Iason PsilopatisIason Psilopatis
Iason Psilopatis
MHMartin Heidinger
Martin Heidinger
SSSeraina Schmid
Seraina Schmid
FSFranziska Siegenthaler
Franziska Siegenthaler
TZTibor A. Zwimpfer
Tibor A. Zwimpfer
Background: Platinum sensitivity is a key predictive and prognostic factor in epithelial tubo-ovarian carcinoma, however early prognostic estimation at multidisciplinary tumour boards remains challenging. Large language models can process unstructured clinical narratives, but their prognostic utility in gynaecological oncology remains unclear. We compared the performance of contemporary large language models with that of gynaecological oncologists in predicting platinum sensitivity and overall survival from baseline tumour board data. Methods: In this retrospective cohort study, 69 patients with epithelial tubo-ovarian carcinoma were included. Standardized vignettes were independently assessed by five models using identical prompts and by three gynaecological oncologists from different institutions. Both models and experts classified platinum sensitivity (recurrence ≤6 months vs >6 months after first-line platinum-based therapy), overall survival ( < 2, 2–5, >5 years), and confidence (low, moderate, high). Exploratory analyses assessed performance by confidence level, neoadjuvant chemotherapy, case difficulty, and repeated assessment of LLM predictions. Results: 86% of patients were platinum-sensitive. Platinum sensitivity accuracy ranged from 50.7% to 85.5% among large language models and from 49.3 % to 76.8% among experts, with no significant difference between groups ( P = 0.304). Large language models showed high sensitivity (52.5–100%) but low specificity (0–40%). Survival prediction accuracy was moderate (40.6–52.2% for large language models; 44.8–49.3% for experts), with no significant difference between groups ( P = 0.671). Accuracy increased with higher confidence but declined in neoadjuvant-treated patients and complex cases. In repeated assessments, mean model accuracy decreased for platinum sensitivity (71.5% to 62.6%) and overall survival (45.2% to 40.0%). Conclusion: Large language models achieved similar overall accuracy to gynaecological oncologists when predicting platinum sensitivity and overall survival. However, limited specificity for platinum resistance, lower performance in complex cases, and temporal variability highlight important limitations. Large language models may serve as adjunctive decision-support tools but require prospective validation before clinical implementation.